معرفی
Vera Golder is an Associate Professor at the School of Clinical Sciences at Monash Health, Monash University, specializing in rheumatology with a focus on systemic lupus erythematosus (SLE). With 47 research outputs documented between 2013-2025, she is an active contributor to the field of autoimmune disease research and treatment.
Dr. Golder's research primarily centers on disease activity measurement, treatment outcomes, and patient management in systemic lupus erythematosus. Her work investigates the lupus low disease activity state (LLDAS) as a treatment target, remission definitions, and the impact of various therapeutic approaches on long-term outcomes. She has been instrumental in developing assessment tools and treatment response measures for SLE, contributing to international consensus efforts on treat-to-target strategies in lupus management.
Analysis of her recent publications (2023-2025) reveals a strong focus on multinational collaborative research through the Asia Pacific Lupus Collaboration. Her work examines disease activity states, treatment response measures, and the relationship between disease control and long-term outcomes in SLE patients. A significant portion of her research addresses the implementation of standardized measurement tools in clinical trials and routine care, with emphasis on domain-specific disease activity and the development of novel outcome measures.
Dr. Golder has been involved in significant research projects including 'The Monash Health Cost of SLE study' (2016-2018) where she served as an Associate Investigator. Her collaborative network spans multiple countries across the Asia-Pacific region, reflecting the multinational nature of her research on lupus. She frequently collaborates with leading researchers in the field including Morand, Hoi, and Kandane-Rathnayake, contributing to the advancement of SLE management strategies worldwide.
